Demant A/S (WILYY)
OTCMKTS · Delayed Price · Currency is USD
18.99
-0.28 (-1.44%)
At close: Aug 13, 2025
Demant Market Cap
Demant has a market cap or net worth of $8.44 billion as of August 21, 2025. Its market cap has increased by 1.13% in one year.
Market Cap
8.44B
Enterprise Value
10.80B
Revenue
3.56B
Ranking
n/a
PE Ratio
23.26
Stock Price
$18.99
Market Cap Chart
Since November 21, 1995, Demant's market cap has increased from 388.01M to 8.44B, an increase of 2,075.78%. That is a compound annual growth rate of 10.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2025 | 8.53B | 6.59% |
| Dec 30, 2024 | 8.00B | -15.86% |
| Dec 29, 2023 | 9.51B | 56.03% |
| Dec 30, 2022 | 6.10B | -50.08% |
| Dec 30, 2021 | 12.21B | 28.27% |
| Dec 30, 2020 | 9.52B | 23.21% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.45M |
| Glass House Brands | 554.44M |
| Nika Pharmaceuticals | 453.04M |
| CytoDyn | 363.56M |
| Northwest Biotherapeutics | 355.76M |
| American Oncology Network | 355.44M |